SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-007735 to CareMax, Inc. (CMAX, CMAXW) (CIK 0001813914)

CareMax, Inc. (CMAX, CMAXW) (CIK 0001813914)
Date: July 20, 2023 · CIK: 0001813914 · Accession: 0000000000-23-007735

AI Filing Summary & Sentiment

Referenced dates: June 27, 2023

Date
July 20, 2023
Author
Not clearly detected
Form
UPLOAD
Company
CareMax, Inc. (CMAX, CMAXW) (CIK 0001813914)

Letter

United States securities and exchange commission logo July 20, 2023 Kevin Wirges Chief Financial Officer and Treasurer CareMax, Inc. 1000 NW 57th Court, Suite 400 Miami, Florida 33126 Re:CareMax, Inc. Form 10-K for the Year Ended December 31, 2022 Form 10-K/A for the Year Ended December 31, 2021 Correspondence Letter dated June 27, 2023 File No. 1-39391 Dear Kevin Wirges: We have reviewed your June 27, 2023 response to our comment letter and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to these comments within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe our comments apply to your facts and circumstances, please tell us why in your response. After reviewing your response to these comments, we may have additional comments. Unless we note otherwise, our references to prior comments are to comments in our June 14, 2023 letter. Form 10-K for the Year Ended December 31, 2022 Adjusted EBITDA, page 69 1.We note your response to comment 1. The adjustments for stay-on bonuses and duplicative salaries in your determination of Adjusted EBITDA are inconsistent with Question 100.01 of the Non-GAAP Financial Measures Compliance & Disclosure Interpretations, as updated. In this regard, please revise your determination of Adjusted EBITDA to remove these adjustments.

FirstName LastNameKevin Wirges Comapany NameCareMax, Inc. July 20, 2023 Page 2 FirstName LastName Kevin Wirges CareMax, Inc. July 20, 2023 Page 2 You may contact Nudrat Salik at (202) 551-3692 or Jeanne Baker at (202) 551-3691 if you have any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services

Show Raw Text
United States securities and exchange commission logo
July 20, 2023
Kevin Wirges
Chief Financial Officer and Treasurer
CareMax, Inc.
1000 NW 57th Court, Suite 400
Miami, Florida 33126
Re:CareMax, Inc.
Form 10-K for the Year Ended December 31, 2022
Form 10-K/A for the Year Ended December 31, 2021
Correspondence Letter dated June 27, 2023
File No. 1-39391
Dear Kevin Wirges:
            We have reviewed your June 27, 2023 response to our comment letter and have the
following comments.  In some of our comments, we may ask you to provide us with information
so we may better understand your disclosure.
            Please respond to these comments within ten business days by providing the requested
information or advise us as soon as possible when you will respond.  If you do not believe our
comments apply to your facts and circumstances, please tell us why in your response.
            After reviewing your response to these comments, we may have additional
comments.  Unless we note otherwise, our references to prior comments are to comments in our
June 14, 2023 letter.
Form 10-K for the Year Ended December 31, 2022
Adjusted EBITDA, page 69
1.We note your response to comment 1.  The adjustments for stay-on bonuses and
duplicative salaries in your determination of Adjusted EBITDA are inconsistent
with Question 100.01 of the Non-GAAP Financial Measures Compliance & Disclosure
Interpretations, as updated.  In this regard, please revise your determination of Adjusted
EBITDA to remove these adjustments.

 FirstName LastNameKevin Wirges
 Comapany NameCareMax, Inc.
 July 20, 2023 Page 2
 FirstName LastName
Kevin Wirges
CareMax, Inc.
July 20, 2023
Page 2
            You may contact Nudrat Salik at (202) 551-3692 or Jeanne Baker at (202) 551-3691 if
you have any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services